Contrast-induced nephropathy: comparative effects of different contrast media
Agency for Healthcare Research and Quality (AHRQ)
Record ID 32016000059
English
Authors' recommendations:
In summary, we found low strength of evidence (SOE) to support no differences in contrast-induced nephropathy (CIN) risk between low-osmolar contrast medias (LOCMs) and moderate SOE that iso-osmolar contrast media (IOCM) had a slightly lower risk of CIN than LOCM, but the lower risk was not clinically important and had only borderline statistical significance. No relationship was found between comparative CIN risk and route of administration. For clinicians, these findings suggest that the choice between IOCM and LOCMs will not have an important effect on the risk of CIN.
Details
Project Status:
Completed
Year Published:
2016
URL for published report:
http://www.effectivehealthcare.ahrq.gov/ehc/products/530/2166/nephropathy-contrast-induced-comparison-executive-150107.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Humans
- Contrast Media
- Kidney Diseases
Contact
Organisation Name:
Agency for Healthcare Research and Quality
Contact Address:
Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name:
martin.erlichman@ahrq.hhs.gov
Contact Email:
martin.erlichman@ahrq.hhs.gov
Copyright:
Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.